Search results :

Pimozide

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: N05AG02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2
Asthenia 13.9% - 25% x
Akinesia 8% 0% x
Drowsiness 7% 3% x
Hyperkinesia 2.78% - 5.56% x
Visual disturbance 2.78% - 5.56% 0% x
Muscle tightness 3% 0% x
Dysphagia 2.78% x
Torticollis 2.78% x
Myalgia 2.78% x
Abnormal dreams 2.78% x
Electrocardiogram abnormal 2.78% x
Depression 2% 3% x
Speech disorder 2% 0% x
Diarrhoea 1% 0% x
Increased appetite 1% 0% x
Agranulocytosis postmarketing x
Amenorrhoea postmarketing x
Anaemia postmarketing x
Aplastic anaemia postmarketing x
Haemolytic anaemia postmarketing x
Mental disorder postmarketing x
Breast disorder postmarketing x
Connective tissue disorder postmarketing x
Constipation postmarketing, 4% 2% x x
Dizziness postmarketing, 0% 1% x x
Endocrine disorder postmarketing x
Eosinophilia postmarketing x
Grand mal convulsion postmarketing x
Rash postmarketing, 2.78% - 8.33% x x
Extrapyramidal disorder postmarketing x
Eye disorder postmarketing x
Faecal incontinence postmarketing x
Gastrointestinal disorder postmarketing x
Gingival hyperplasia postmarketing x
Gynaecomastia postmarketing x
Headache postmarketing, 1% - 22.2% 2% x x
Cardiac disorder postmarketing x
Blood disorder postmarketing x
Hyperhidrosis postmarketing x
Hyperprolactinaemia postmarketing x
Hyponatraemia postmarketing x
Body temperature decreased postmarketing x
Leukopenia postmarketing x
Muscle rigidity postmarketing, 2% 0% x x
Nervous system disorder postmarketing x
Neuroleptic malignant syndrome postmarketing x x
Pancytopenia postmarketing x
Pruritus postmarketing x
Convulsion postmarketing x
Salivary hypersecretion postmarketing, 5.56% - 13.9% x x
Torsade de pointes postmarketing x
Tremor postmarketing, 2.78% x x
Urticaria postmarketing x
Ventricular fibrillation postmarketing x
Ventricular tachycardia postmarketing x
Dry mouth postmarketing, 5% 1% x x
Urinary retention postmarketing x
Cogwheel rigidity postmarketing x
Electroencephalogram abnormal postmarketing x
Electrocardiogram QT prolonged postmarketing x
Unspecified disorder of skin and subcutaneous tissue postmarketing x
Bradykinesia postmarketing x
Galactorrhoea postmarketing x
Erectile dysfunction postmarketing, 3% 0% x x
Vision blurred postmarketing x x
Akathisia postmarketing, 8% 0% x x
Tardive dyskinesia postmarketing x x
Thrombocytopenic purpura postmarketing x
Insomnia postmarketing, 2% 2% x x
Oculogyration postmarketing x
Nuchal rigidity postmarketing x
Somnolence postmarketing, 25% - 27.8% x x
Anorexia x
Chest pain x
Dyskinesia x
Eructation 0% 1% x
Hypertension x
Hypotension x
Orthostatic hypotension x
Menstrual disorder 0% 1% x
Cramp muscle 0% 1% x
Nausea 0% 2% x
Nocturia x
Palpitations x
Vermiculation x
Schizophrenia x
Sweating x
Syncope x
Tachycardia x
Pollakiuria x
Vomiting 0% 1% x
Weight increased x
Weight decreased x
Oculogyric crisis x
Cataract x
Periorbital oedema x
Opisthotonus x
Hyperreflexia x
Skin irritation x
Electrocardiogram U wave present x
Excitement 0% 1% x
Extrapyramidal symptoms x
Protrusion tongue x
Parkinsonism x
Hyperpyrexia x
Movements involuntary x
Tonic-clonic seizures x
Spots before eyes 0% 1% x
Distress gastrointestinal x
Motor restlessness x
Electrocardiogram change x
Loss of libido x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

PIMOZIDE / PMS-PIMOZIDE

Side effects:53
Source:Health Canada

pimozide

Side effects:74
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label